Eli Lily cuts 2024 revenue guidance by $400M, shares sink 8%

Eli Lilly saw its shares crash in early trade on Tuesday as the pharm major provided its revenue outlook for 2024 and 2025. The pharma major cut its revenue guidance…
Input your search keywords and press Enter.